Agreed. I think this could be a good buying Opp although I'm not sure bottom is in yet. The reason I believe it's slipping is due to the uncertainty of when the MRI data will come and with that a potential partnership for Trimesta.
They filed a 200 million shelf also which may have spooked a few out. In my opinion the partnership and terms of the partnership will be the key to derisking at least part of the shelf offering that will have to take place before PIII. A great partnership for Trimesta with cash is what I believe a lot are waiting on here.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.